152 related articles for article (PubMed ID: 17952115)
1. Regulation of c-met expression by transcription repressor Daxx.
Morozov VM; Massoll NA; Vladimirova OV; Maul GG; Ishov AM
Oncogene; 2008 Apr; 27(15):2177-86. PubMed ID: 17952115
[TBL] [Abstract][Full Text] [Related]
2. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
3. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
4. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
Zou JN; Wang SZ; Yang JS; Luo XG; Xie JH; Xi T
Cancer Lett; 2009 Jul; 280(1):78-85. PubMed ID: 19321255
[TBL] [Abstract][Full Text] [Related]
6. Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells.
Muromoto R; Kuroda M; Togi S; Sekine Y; Nanbo A; Shimoda K; Oritani K; Matsuda T
Eur J Immunol; 2010 Dec; 40(12):3570-80. PubMed ID: 21108476
[TBL] [Abstract][Full Text] [Related]
7. Axin bridges Daxx to p53.
Lin SC; Li Q
Cell Res; 2007 Apr; 17(4):301-2. PubMed ID: 17404597
[No Abstract] [Full Text] [Related]
8. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
Kuo HY; Chang CC; Jeng JC; Hu HM; Lin DY; Maul GG; Kwok RP; Shih HM
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16973-8. PubMed ID: 16287980
[TBL] [Abstract][Full Text] [Related]
9. Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB.
Croxton R; Puto LA; de Belle I; Thomas M; Torii S; Hanaii F; Cuddy M; Reed JC
Cancer Res; 2006 Sep; 66(18):9026-35. PubMed ID: 16982744
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
Herynk MH; Stoeltzing O; Reinmuth N; Parikh NU; Abounader R; Laterra J; Radinsky R; Ellis LM; Gallick GE
Cancer Res; 2003 Jun; 63(11):2990-6. PubMed ID: 12782608
[TBL] [Abstract][Full Text] [Related]
11. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
[TBL] [Abstract][Full Text] [Related]
12. Cloning and functional characterization of a rat Daxx that functions as a corepressor for the androgen receptor.
Mizuta H; Kuroda Y
Cell Biol Int; 2004; 28(8-9):609-14. PubMed ID: 15350595
[TBL] [Abstract][Full Text] [Related]
13. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
Di Renzo MF; Olivero M; Giacomini A; Porte H; Chastre E; Mirossay L; Nordlinger B; Bretti S; Bottardi S; Giordano S
Clin Cancer Res; 1995 Feb; 1(2):147-54. PubMed ID: 9815967
[TBL] [Abstract][Full Text] [Related]
16. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel repressor element in the cyclo-oxygenase-2 promoter and its nuclear binding protein.
Yang X; Lin L; Zhang X; Ji Y; Lv J; Zhu Y; Yin Y; Sun Y; Han X
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1204-8. PubMed ID: 18518878
[TBL] [Abstract][Full Text] [Related]
18. Daxx-mediated transcriptional repression of MMP1 gene is reversed by SPOP.
La M; Kim K; Park J; Won J; Lee JH; Fu YM; Meadows GG; Joe CO
Biochem Biophys Res Commun; 2004 Jul; 320(3):760-5. PubMed ID: 15240113
[TBL] [Abstract][Full Text] [Related]
19. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
20. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]